These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

691 related articles for article (PubMed ID: 28138429)

  • 1. Evaluation of early-phase [
    Daerr S; Brendel M; Zach C; Mille E; Schilling D; Zacherl MJ; Bürger K; Danek A; Pogarell O; Schildan A; Patt M; Barthel H; Sabri O; Bartenstein P; Rominger A
    Neuroimage Clin; 2017; 14():77-86. PubMed ID: 28138429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early [(18)F]florbetaben and [(11)C]PiB PET images are a surrogate biomarker of neuronal injury in Alzheimer's disease.
    Tiepolt S; Hesse S; Patt M; Luthardt J; Schroeter ML; Hoffmann KT; Weise D; Gertz HJ; Sabri O; Barthel H
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1700-9. PubMed ID: 27026271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early-Phase 18F-Florbetaben PET as an Alternative Modality for 18F-FDG PET.
    Son SH; Kang K; Ko PW; Lee HW; Lee SW; Ahn BC; Lee J; Yoon U; Jeong SY
    Clin Nucl Med; 2020 Jan; 45(1):e8-e14. PubMed ID: 31524679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of Dual-Point Amyloid PET Scans in Appropriate Use Criteria: A Multicenter Study.
    Segovia F; Gómez-Río M; Sánchez-Vañó R; Górriz JM; Ramírez J; Triviño-Ibáñez E; Carnero-Pardo C; Martínez-Lozano MD; Sopena-Novales P
    J Alzheimers Dis; 2018; 65(3):765-779. PubMed ID: 30103321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET.
    Brendel M; Schnabel J; Schönecker S; Wagner L; Brendel E; Meyer-Wilmes J; Unterrainer M; Schildan A; Patt M; Prix C; Ackl N; Catak C; Pogarell O; Levin J; Danek A; Buerger K; Bartenstein P; Barthel H; Sabri O; Rominger A
    Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2239-2248. PubMed ID: 28932894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Relevance of [
    Librizzi D; Cabanel N; Zavorotnyy M; Riehl E; Kircher T; Luster M; Hooshyar Yousefi B
    Molecules; 2021 Feb; 26(5):. PubMed ID: 33652938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amyloid positron-emission-tomography with [
    Schönecker S; Prix C; Raiser T; Ackl N; Wlasich E; Stenglein-Krapf G; Mille E; Brendel M; Sabri O; Patt M; Barthel H; Bartenstein P; Levin J; Rominger A; Danek A
    Nervenarzt; 2017 Feb; 88(2):156-161. PubMed ID: 27913818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coupled Imaging with [
    Chiaravalloti A; Castellano AE; Ricci M; Barbagallo G; Sannino P; Ursini F; Karalis G; Schillaci O
    Mol Imaging Biol; 2018 Aug; 20(4):659-666. PubMed ID: 29404839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aβ imaging with 18F-florbetaben in prodromal Alzheimer's disease: a prospective outcome study.
    Ong KT; Villemagne VL; Bahar-Fuchs A; Lamb F; Langdon N; Catafau AM; Stephens AW; Seibyl J; Dinkelborg LM; Reininger CB; Putz B; Rohde B; Masters CL; Rowe CC
    J Neurol Neurosurg Psychiatry; 2015 Apr; 86(4):431-6. PubMed ID: 24970906
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Chang Y; Li C; Yang H; Wu Y; Xu B; Zhang J; Wang R
    Front Neurosci; 2020; 14():745. PubMed ID: 32848542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early-phase [
    Beyer L; Nitschmann A; Barthel H; van Eimeren T; Unterrainer M; Sauerbeck J; Marek K; Song M; Palleis C; Respondek G; Hammes J; Barbe MT; Onur Ö; Jessen F; Saur D; Schroeter ML; Rumpf JJ; Rullmann M; Schildan A; Patt M; Neumaier B; Barret O; Madonia J; Russell DS; Stephens AW; Roeber S; Herms J; Bötzel K; Levin J; Classen J; Höglinger GU; Bartenstein P; Villemagne V; Drzezga A; Seibyl J; Sabri O; Brendel M
    Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2911-2922. PubMed ID: 32318783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.
    Brendel M; Delker A; Rötzer C; Böning G; Carlsen J; Cyran C; Mille E; Gildehaus FJ; Cumming P; Baumann K; Steiner H; Haass C; Herms J; Bartenstein P; Rominger A
    Neuroimage; 2014 Jan; 84():843-53. PubMed ID: 24055703
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Rowe CC; Doré V; Jones G; Baxendale D; Mulligan RS; Bullich S; Stephens AW; De Santi S; Masters CL; Dinkelborg L; Villemagne VL
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2053-2059. PubMed ID: 28643043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease.
    Villemagne VL; Mulligan RS; Pejoska S; Ong K; Jones G; O'Keefe G; Chan JG; Young K; Tochon-Danguy H; Masters CL; Rowe CC
    Eur J Nucl Med Mol Imaging; 2012 Jun; 39(6):983-9. PubMed ID: 22398958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls.
    Barthel H; Luthardt J; Becker G; Patt M; Hammerstein E; Hartwig K; Eggers B; Sattler B; Schildan A; Hesse S; Meyer PM; Wolf H; Zimmermann T; Reischl J; Rohde B; Gertz HJ; Reininger C; Sabri O
    Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1702-14. PubMed ID: 21547601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual Time-Point [18F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer's Disease.
    Florek L; Tiepolt S; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Luthardt J; Sattler B; Patt M; Hoffmann KT; Villringer A; Classen J; Gertz HJ; Sabri O; Barthel H
    J Alzheimers Dis; 2018; 66(3):1105-1116. PubMed ID: 30400095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias.
    Villemagne VL; Ong K; Mulligan RS; Holl G; Pejoska S; Jones G; O'Keefe G; Ackerman U; Tochon-Danguy H; Chan JG; Reininger CB; Fels L; Putz B; Rohde B; Masters CL; Rowe CC
    J Nucl Med; 2011 Aug; 52(8):1210-7. PubMed ID: 21764791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head-to-Head Comparison of 18F-Florbetaben and 18F-Flutemetamol in the Cortical and Striatal Regions.
    Cho SH; Choe YS; Kim YJ; Kim HJ; Jang H; Kim Y; Kim SE; Kim SJ; Kim JP; Jung YH; Kim BC; Lockhart SN; Farrar G; Na DL; Moon SH; Seo SW
    J Alzheimers Dis; 2020; 76(1):281-290. PubMed ID: 32474468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimized classification of
    Bullich S; Seibyl J; Catafau AM; Jovalekic A; Koglin N; Barthel H; Sabri O; De Santi S
    Neuroimage Clin; 2017; 15():325-332. PubMed ID: 28560157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated cerebral blood flow proxy with increased beta-amyloid burden in Alzheimer's disease preclinical phase evaluated by dual-phase
    Kim GH; Kim BR; Yoon HJ; Jeong JH
    Sci Rep; 2024 Aug; 14(1):18480. PubMed ID: 39122860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.